ATARA BIOTHERAPEUTICS INC's ticker is ATRA and the CUSIP is 046513107. A total of 151 filers reported holding ATARA BIOTHERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.30 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,776,000 | +10.3% | 1,200,000 | +20.0% | 0.14% | +19.0% |
| Q2 2023 | $1,610,000 | -67.2% | 1,000,000 | -23.1% | 0.12% | -69.5% |
| Q3 2022 | $4,914,000 | -69.2% | 1,300,000 | -36.4% | 0.38% | -66.2% |
| Q2 2022 | $15,930,000 | -6.3% | 2,045,000 | +11.7% | 1.12% | +23.6% |
| Q1 2022 | $17,001,000 | -39.4% | 1,830,000 | +2.7% | 0.91% | -11.9% |
| Q4 2021 | $28,073,000 | -12.0% | 1,781,234 | 0.0% | 1.03% | -17.0% |
| Q3 2021 | $31,885,000 | +202.6% | 1,781,234 | +162.8% | 1.24% | +241.8% |
| Q2 2021 | $10,538,000 | +232.3% | 677,683 | +206.9% | 0.36% | +116.7% |
| Q1 2021 | $3,171,000 | -26.9% | 220,848 | 0.0% | 0.17% | -18.0% |
| Q4 2020 | $4,335,000 | +51.5% | 220,848 | 0.0% | 0.20% | -2.4% |
| Q3 2020 | $2,862,000 | -11.1% | 220,848 | 0.0% | 0.21% | -18.6% |
| Q2 2020 | $3,218,000 | +681.1% | 220,848 | +783.4% | 0.26% | +448.9% |
| Q4 2019 | $412,000 | – | 25,000 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Antipodean Advisors LLC | 1,000,000 | $3,280,000 | 10.95% |
| M28 Capital Management LP | 439,300 | $1,440,904 | 1.37% |
| Redmile Group, LLC | 6,242,756 | $20,476,240 | 0.84% |
| MAVERICK CAPITAL LTD | 6,291,013 | $20,634,523 | 0.49% |
| Baupost Group | 8,123,616 | $26,645 | 0.44% |
| JOSH ARNOLD INVESTMENT CONSULTANT, LLC | 52,000 | $171 | 0.25% |
| WASATCH ADVISORS LP | 8,391,014 | $27,522,525 | 0.18% |
| PACIFIC HEIGHTS ASSET MANAGEMENT LLC | 525,000 | $1,722,000 | 0.17% |
| STALEY CAPITAL ADVISERS INC | 450,000 | $1,476 | 0.09% |
| Virtus ETF Advisers LLC | 36,100 | $118,408 | 0.06% |